Ben Hsing's practice focuses on litigation and trials before the U.S. district courts and the U.S. International Trade Commission, and appeals to the U.S. Court of Appeals for the Federal Circuit, concentrating on enforcement of U.S. patent rights. In a patent trial victory, the trial judge commented that Ben's direct examination of an expert witness "was wonderful" and that he "never [has] seen such a thorough examination of a witness in [his] life."
In addition to his litigation and appellate practice, Ben counsels a variety of U.S. and international clients regarding U.S. intellectual property law by providing them with infringement, validity, enforceability and clearance opinions, and by advising them in licensing and antitrust matters. Ben also has extensive experience in conducting intellectual property due diligence investigations in connection with acquisitions and licensing deals. He also counsels and assists clients in procuring both U.S. and foreign patents.
Ben's practice has encompassed an array of technologies, including chemicals, biotechnology, pharmaceuticals, polymers and semiconductors. For example, he has counseled clients and litigated in the fields of pharmaceutical compounds and formulations, genetically engineered seeds, industrial and environmental catalysts, fibers, memory chips, and imaging devices. He obtained invaluable experience in the prosecution of patent applications before the U.S. Patent and Trademark Office by serving as a Patent Examiner for four years.
Ben is a former member of the Council of the Intellectual Property Law Section of the American Bar Association. In 2009 he was selected by Super Lawyers for the fourth consecutive year.
Worked four years as Patent Examiner in the United States Patent and Trademark Office in the areas of electrochemistry, chemical coating processes, and polymeric compositions.
Prosecuted hundreds of patent applications involving pharmaceuticals, chemical compounds and compositions, polymers, and biotechnology.
Authored numerous opinions on patents involving chemicals, polymer resins, genetically engineered seeds, pharmaceuticals, imaging devices, and telecommunication systems.